Avanos Medical AVNS Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's cash provided by (used in) financing activity, including discontinued operation?
- Avanos Medical (AVNS) reported cash provided by (used in) financing activity, including discontinued operation of -$3.2M in Q1 2026.
- How has Avanos Medical's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- Avanos Medical's cash provided by (used in) financing activity, including discontinued operation increased by 89.0% year-over-year, from -$29.1M to -$3.2M.
- What is the long-term trend for Avanos Medical's cash provided by (used in) financing activity, including discontinued operation?
- Over 3 years (2021 to 2025), Avanos Medical's cash provided by (used in) financing activity, including discontinued operation has grown at a -12.5% compound annual growth rate (CAGR), from -$55.3M to -$37M.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.